Krystal Biotech Total Assets (Quarterly) Analysis

Krystal Biotech Inc (KRYS)

182.29 +4.19 (+2.35%) USD | NASDAQ | Nov 21, 16:00

182.39 +0.10 (+0.05%) After-Hours: 07:21

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
September 30, 2024	982.32M
June 30, 2024	917.66M
March 31, 2024	853.30M
December 31, 2023	818.36M
September 30, 2023	790.35M
June 30, 2023	684.03M
March 31, 2023	531.85M
December 31, 2022	558.45M
September 30, 2022	576.38M
June 30, 2022	601.32M
March 31, 2022	616.87M
December 31, 2021	626.30M
September 30, 2021	451.10M
June 30, 2021	443.56M
March 31, 2021	443.02M
December 31, 2020	310.84M

Date	Value
September 30, 2020	311.45M
June 30, 2020	318.14M
March 31, 2020	205.13M
December 31, 2019	209.02M
September 30, 2019	214.23M
June 30, 2019	205.16M
March 31, 2019	115.70M
December 31, 2018	116.12M
September 30, 2018	54.45M
June 30, 2018	46.03M
March 31, 2018	47.85M
December 31, 2017	50.11M
September 30, 2017	52.67M
June 30, 2017	3.977M
December 31, 2016	2.182M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

205.13M

Minimum

Mar 2020

982.32M

Maximum

Sep 2024

562.47M

Average

567.41M

Median

Total Assets (Quarterly) Benchmarks

Bioventus Inc	769.49M
ADMA Biologics Inc	390.62M
Alnylam Pharmaceuticals Inc	4.205B
Amicus Therapeutics Inc	786.56M
Rhythm Pharmaceuticals Inc	363.57M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	96.47M
Shareholders Equity (Quarterly)	885.85M
Current Ratio	7.966